Our objective at Onxeo is to maintain an open, rich dialogue with our shareholders, our potential investors and the financial community at large. We keep you informed on a regular basis of the progress made by the Company in order to help you with your analysis and make it easier for you to understand the Company’s added value.

Agenda >

BioMed Event

January 22, 2019

Investor meetings around the JP Morgan Healthcare Conference 2019

January 7-10, 2019


November 5-7, 2018

Conference call on the Interim Results from Phase 1 Study of AsiDNA™

November 5, 2018 - 5:30 pm CET / 11:30 am ET

Boursocap / Les Echos – Investir Event

November 21, 2018